It is an update to the previous statement on the types of data requested in October 2024. 1 To inform decisions on COVID-19 vaccine antigen composition, 2-6 the TAG-CO-VAC reviews data (see Table) on the genetic evolution of SARS-CoV-2 and the antigenic characteristics of previously and currently circulating variants.
